Eugene

[email protected]

LATEST

FDA Issues Update on Its Actions for Coronavirus Medical Countermeasures
By

By
The US Food and Drug Administration (FDA) has outlined its actions to advance development of coronavirus (2019-nCoV) medical countermeasures for the outbreak in Wuhan, China. This includes collaboration with interagency…

J&J Initiates Vaccine Development for Coronavirus in Response to Outbreak
By

By
Johnson & Johnson (J&J) has announced that it is launching a multi-pronged response to the coronavirus (2019-nCoV or Wuhan coronavirus) outbreak, which includes initiating development of a vaccine candidate against…

Just-Evotec Biologics in Capacity Pact with Merck & Co.; Piramal Expands
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Piramal, Just-Evotec Biologics, Cognate BioServices, Cobra Biologics, and Jones Healthcare Group. Chemicals/Chemical API Manufacturing Piramal Pharma Invests $19 M…

Global Pharma Briefs: News from Asia, Europe and the US
By

By
A roundup of developments and latest news from China (WuXi Biologics), India (Biocon), UK (AstraZeneca), US (Krystal Biotech). China WuXi Biologics Provides Update on Activities Relating to Coronavirus in China…

Sanofi Completes $2.5-Bn Acquisition of Cancer Therapy Company Synthorx
By

By
Sanofi has completed its $2.5-billion acquisition of Synthorx, a clinical-stage biotechnology company developing treatments for cancer and autoimmune disorders. With the completion of the deal, Sanofi will gain access to…

Allergan Opens New $176-M Biologics Facility in Ireland
By

By
Allergan has opened an EUR 160 million ($176 million) biologics facility at its Westport Campus in County Mayo, Ireland. The new facility will act as a global hub for Allergan’s…

Pfizer Launches Global Centers of Excellence for Vaccines
By

By
Pfizer has launched its Vaccines Division’s Centers of Excellence Network, a global program of collaborations with academic institutions to conduct real-world epidemiologic research to accurately identify and measure the burden…

Merck KGaA To Invest $275 M in Biotech Development and Mfg Facility
By

By
Merck KGaA is investing EUR 250 million ($275 million) over the 2019-2022 period in a new Biotech Development Center for biopharmaceutical development and manufacturing for new biological entities in clinical…

AbbVie, Allergan To Divest Three Drugs to AstraZeneca and Nestlé
By

By
As part of the ongoing regulatory approval process for AbbVie’s pending $63-billion acquisition of Allergan, Allergan has agreed to divest three drugs: one investigational drug to AstraZeneca and two commercial…

CEO of New Lonza, Chr. Hansen JV Named; Alcami, GE Healthcare Expand
By

By
The latest news from CDMOs, CMOs, and suppliers featuring Lonza, Alcami, GE Healthcare, Charles River, Hitachi, and Packaging Technology Group. Biologics Manufacturing GE Healthcare Life Sciences To Build New Facility…